Provide a nurturing environment and harm free care

 TLC technology

Flexible contact layer featuring the TLC* Healing Matrix

UrgoTul is a non-adherent, highly conformable contact layer featuring the TLC* Healing Matrix to provide a nurturing environment for healing and harm free care for your patient.

*TLC: Technology Lipido-Colloid

Benefits

Providing harm free care
- No pain at dressing changes (1)
- Will not damage newly formed tissue (2,3,4)


Providing a nurturing environment for healing
- Enables key cells for healing (5,6)
- Maintains a moist wound healing environment (2,3,7,8)
- Non-adherence to the wound bed (9)
- Protects the surrounding skin (3,9,10)

 

Indications

  • Suitable for non to highly exuding wounds when combined with a secondary dressing suitable for the level of exudate.
  • Highly conformable to pack cavity wounds
  • Can be cut to fit hard to dress areas

Instructions for Use

  • Cover UrgoTul with a secondary dressing suitable to absorb the level of wound exudate.
  • Hold dressing in place with a conforming bandage such as K-Band or K-Lite, adhesive tape or an elasticated tubular bandage.
  • Can be left in place for up to 7 days but may need to be changed more frequently depending on the level of exudate and the clinical condition of the wound.

 

Sizes :

 

Size Pack Size Product Code NPC** Code PIP Code
5cm x 5cm 40 504005 EKB056 354-5498
10cm x 10cm 25 504008 EKB057 354-5506
15cm x 15cm 10 550027 EKB074 371-9432
15cm x 20cm 16 504011 EKB058 354-5514
10cm x 40cm 10 504009 EKB082 298-3260
20cm x 30cm 5 504012 EKB060 354-5480

 **NPC: NHS Supply Chain ordering code

  References:

1. Meaume et al. The importance of pain reduction through dressing selection in routine wound management:the MAPP study, Journal of Wound Care, 2004, Vol 13, No 10, 409-413.
2. M. Le Berre, Y. Lurton et al., Pansements imprégnés : tulles/ interfaces. Poster, CPC 2005, Paris.
3. Parpex P. et al. Management of venous leg ulcers with Cellosorb® Micro-adherent dressing: results of a multi-centre clinical trial. Phlebologie 2010; 63: 76-82
4. Meaume S. Urgotul®: a novel non-adherent lipidocolloid dressing. British Journal of Nursing. 2002, Vol 11, N°16.
5. Bernard FX. , Barrault C. et al., Stimulation of the proliferation of human dermal fbroblasts in vitro by a lipidocolloïd dressing. Journal of Wound Care, May 2005; 14 (5) : 215-220. (Study conducted on Urgotul)
6. FX. Bernard, F. Juchaux et al., Effets d’un pansement lipido-colloïde sur la production de matrice extracellulaire.Journal des Plaies et Cicatrisations, 2007. (Study conducted on Urgotul)
7. Report No. RE/DA/2013-164/LAP
8. Benbow M. A clinical evaluation of Urgotul® to treat acute and chronic wounds. British Journal of Nursing. 2004. Vol 13, N°2: 105-109.
9. White R. Supporting evidence - based practice: a clinical review of TLC technology, J Wound Care 2015
10. Meaume S. et al. Optimizing wound care with a new lipido-colloid dressing (Urgotul Duo). British Journal of Nursing 2007; 16(6).